Morgan Stanley analyst David Lewis reiterated an Overweight rating and $93.00 price target on Abbott Labs (NYSE: ABT) after the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE